Oragenics Statistics
Total Valuation
Oragenics has a market cap or net worth of $5.49 million. The enterprise value is $6.52 million.
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Oragenics has 4.13 million shares outstanding. The number of shares has increased by 355.75% in one year.
| Current Share Class | 4.13M |
| Shares Outstanding | 4.13M |
| Shares Change (YoY) | +355.75% |
| Shares Change (QoQ) | +20.53% |
| Owned by Insiders (%) | 0.41% |
| Owned by Institutions (%) | 3.26% |
| Float | 4.03M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.50
| Current Ratio | 0.50 |
| Quick Ratio | 0.46 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -12.03 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -245.73% |
| Return on Invested Capital (ROIC) | -541.98% |
| Return on Capital Employed (ROCE) | 448.05% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.06M |
| Employee Count | 5 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.91% in the last 52 weeks. The beta is 0.83, so Oragenics's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | -85.91% |
| 50-Day Moving Average | 1.24 |
| 200-Day Moving Average | 4.42 |
| Relative Strength Index (RSI) | 51.56 |
| Average Volume (20 Days) | 214,894 |
Short Selling Information
The latest short interest is 92,847, so 2.25% of the outstanding shares have been sold short.
| Short Interest | 92,847 |
| Short Previous Month | 117,393 |
| Short % of Shares Out | 2.25% |
| Short % of Float | 2.31% |
| Short Ratio (days to cover) | 0.39 |
Income Statement
| Revenue | n/a |
| Gross Profit | -3.34M |
| Operating Income | -9.53M |
| Pretax Income | -10.30M |
| Net Income | -10.30M |
| EBITDA | n/a |
| EBIT | -9.53M |
| Earnings Per Share (EPS) | -$20.91 |
Full Income StatementBalance Sheet
The company has $1.97 million in cash and $3.00 million in debt, giving a net cash position of -$1.03 million or -$0.25 per share.
| Cash & Cash Equivalents | 1.97M |
| Total Debt | 3.00M |
| Net Cash | -1.03M |
| Net Cash Per Share | -$0.25 |
| Equity (Book Value) | -2.13M |
| Book Value Per Share | -2.59 |
| Working Capital | -2.13M |
Full Balance SheetCash Flow
| Operating Cash Flow | -7.42M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.42M |
| FCF Per Share | -$1.80 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
